rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    INM
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      InMed Pharmaceuticals Completes Closing of Merger with Mentari Therapeutics
      Nov 6Yahoo FinanceINM
      InMed Announces Expected Closing of Merger and Commencement of Trading on Nasdaq Under the Name "Mentari Therapeutics, Inc." and Ticker Symbol "MTRI"
      Nov 5Yahoo FinanceINM
      InMed completes 1-for-10 reverse stock split, changes name
      Nov 4Investing.comINM
      InMed Announces Results of 2026 Annual General and Special Meeting, Approval of Corporate Name Change and Completion of Share Consolidation
      Nov 4Yahoo FinanceINM
      InMed Reports First Quarter Fiscal 2027 Financial Results and Provides Corporate Update
      Nov 3Yahoo FinanceINM
      InMed Announces Share Consolidation in Connection with Proposed Merger
      Nov 2Yahoo FinanceINM
      InMed Sets CVR Record Date Ahead of Mentari Merger Vote

      Tipranks Press Release.

      Oct 28The Globe and MailINM
      InMed Announces CVR Distribution Record Date in Connection with Proposed Merger
      Oct 27Yahoo FinanceINM
      InMed Faces Nasdaq Equity Shortfall but Banks on Mentari Merger to Regain Compliance

      Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

      Sep 19The Globe and MailINM
      InMed receives Nasdaq deficiency notice on equity requirement
      Sep 18Investing.comINM
      InMed Pharmaceuticals Receives Nasdaq Notification Regarding Minimum Shareholders' Equity Compliance

      Vancouver, British Columbia--(Newsfile Corp. - September 18, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, announces that it has received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq"), notifying the Company that the shareholders' equity of $1,075,007 as reported in the...

      Sep 18Yahoo FinanceINM
      InMed Reports Full Year Fiscal 2026 Financial Results and Provides Corporate Update

      Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today reported financial results for its fiscal year ended June 30, 2026.The Company's full financial statements and related MD&A for the fiscal year ended June 30, 2026, are available at www.inmedpharma.com,...

      Sep 9Yahoo FinanceINM

      This is the newest page. Registered accounts read further back.